Parcel.jpg
ParcelPal Announces Deal with Bayshore Specialty Rx (subsidiary of Bayshore Health)
April 05, 2021 07:00 ET | ParcelPal Technology Inc.
VANCOUVER, British Columbia, April 05, 2021 (GLOBE NEWSWIRE) -- ParcelPal Technology Inc. (“ParcelPal” or the “Company”), (OTC:PTNYF) (CSE:PKG) (FSE:PT0) is pleased to announce the signing of an...
CHAMPION.jpg
ChampionX Announces First Quarter 2021 Earnings Release and Conference Call Schedule
April 05, 2021 07:00 ET | ChampionX Corporation
THE WOODLANDS, Texas, April 05, 2021 (GLOBE NEWSWIRE) -- ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX) announced today that it will release its first quarter 2021 operating...
Logo 1.JPG
Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe Disease
April 05, 2021 07:00 ET | Passage Bio
- Krabbe disease, a rare lysosomal storage disorder, has no approved disease-modifying treatment options - Urgency for effective treatment underscored by European Commission designation for...
CidaraLogo (1).jpg
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
April 05, 2021 07:00 ET | Cidara Therapeutics, Inc.
Collaboration includes exclusive worldwide rights to Cidara’s CD388 and other influenza Antiviral Conjugates (AVCs) for up to $780 million in upfront, milestone payments and R&D funding Cidara to...
Bio-Path Logo.jpg
Bio-Path Holdings Announces Successful Completion of Safety Cohort of Triple Combination of Prexigebersen, Decitabine and Venetoclax in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leukemia
April 05, 2021 07:00 ET | Bio-Path Holdings, Inc.
HOUSTON, April 05, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Strengthens Business Development Team to Drive Customer Growth and Diversification
April 05, 2021 07:00 ET | Recro Pharma, Inc.
Six Recent Hires Provide Broader Coverage and Expanded Capabilities in the Areas of Sales and Marketing Significant Traction Already Achieved in First Months of 2021 MALVERN, Pa., April 05, 2021 ...
molecular.jpg
Molecular Templates to Prioritize Next-Generation ETB Candidates
April 05, 2021 07:00 ET | Molecular Templates, Inc.
Molecular Templates to Assume Full Rights to TAK-169, Second Generation ETB Targeting CD38 for the Treatment of Multiple Myeloma Development of First-Generation ETB MT-3724 Has Been Discontinued,...
journeylogo (1).jpg
Journey Medical Corporation Enters $7.5 Million Line of Credit Agreement with East West Bank
April 05, 2021 07:00 ET | Journey Medical Corporation
SCOTTSDALE, Ariz. and NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”), a partner company of Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), today...
akoustis tm.jpg
Akoustis Filters Approved for Use in Multiple WiFi 6E Designs by 2nd Tier-1 SoC Vendor
April 05, 2021 07:00 ET | Akoustis, Inc.
XBAW WiFi 6E Coexistence Filter Solution Has Been Evaluated and Approved for Multiple ChipsetsNew Market Leading SoC Customer Will Create a One-to-Many Sales Opportunity for XBAW WiFi 6E...
agrify.png
Agrify Announces Receipt of $3.5M Purchase Contract, Expanding Customer Relationship with WhiteCloud Botanicals
April 05, 2021 07:00 ET | Agrify
BURLINGTON, Mass., April 05, 2021 (GLOBE NEWSWIRE) --  Agrify Corporation (NasdaqCM:AGFY) (“Agrify” or the “Company”), a developer of highly advanced and proprietary precision hardware and software...